Evaluating Control of Hypertension - Effect of Social Determinants (ECHOES)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients in intervention and control states aged 19-64
Exclusion Criteria:
- Patients outside of age range 19-64
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Medicaid Expansion States
Patients receiving care in community health centers in states that expanded Medicaid (intervention group)
|
There will be no direct intervention, but rather an observation of change based on whether a state expanded Medicaid or not
|
|
Non Medicaid Expansion States
Patients receiving care in community health centers in states that did not expand Medicaid (control group)
|
There will be no direct intervention, but rather an observation of change based on whether a state expanded Medicaid or not
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hypertension incidence
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
Rates of hypertension diagnosis using the following codes in the EHR: ICD-9: 401.00-401.99,
402.00-405.99 or ICD-10: I10-I15.
|
24 months prior to Medicaid expansion vs 24 months post
|
|
Undiagnosed hypertension
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
high blood pressure but no diagnosis or medications can be noted in the EHR diagnostic codes that can be used to document why a diagnosis of hypertension was not made including ICD-10 R03.0 (i.e., white coat syndrome without HTN) and ICD-9 796.2 (i.e., elevated BP without HTN).
|
24 months prior to Medicaid expansion vs 24 months post
|
|
Hypertension screening
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
rate of blood pressure screening marked in EHR
|
24 months prior to Medicaid expansion vs 24 months post
|
|
Hypertension treatment
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
the number of anti-hypertensive medications prescribed in EHR
|
24 months prior to Medicaid expansion vs 24 months post
|
|
Hypertension management
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
blood pressure control: last measure within range of normal for age/risk(s); percent Y/N at last visit, value/date of last measure
|
24 months prior to Medicaid expansion vs 24 months post
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insurance status and rates of coverage
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
Health insurance status derived from EHR data and is primarily based on information collected at each visit
|
24 months prior to Medicaid expansion vs 24 months post
|
|
Service Utilization
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
Type of internal services utilized including number and ratio of "traditional" face to face visits vs. "nontraditional" encounters and communication via phone, personal health record, and email
|
24 months prior to Medicaid expansion vs 24 months post
|
|
Preventive service receipt
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
number of all billed encounters overall and yearly, as well as number of cancer screening, smoking screening, lipid screening, diabetes screening, obesity screening
|
24 months prior to Medicaid expansion vs 24 months post
|
|
Hypertension related complications
Time Frame: 24 months prior to Medicaid expansion vs 24 months post
|
incidence of related complications and diseases derived from EHR data
|
24 months prior to Medicaid expansion vs 24 months post
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
General Publications
- Huguet N, Larson A, Angier H, Marino M, Green BB, Moreno L, DeVoe JE. Rates of Undiagnosed Hypertension and Diagnosed Hypertension Without Anti-hypertensive Medication Following the Affordable Care Act. Am J Hypertens. 2021 Sep 22;34(9):989-998. doi: 10.1093/ajh/hpab069.
- Angier H, Huguet N, Marino M, Green B, Holderness H, Gold R, Hoopes M, DeVoe J. Observational study protocol for evaluating control of hypertension and the effects of social determinants. BMJ Open. 2019 Mar 15;9(3):e025975. doi: 10.1136/bmjopen-2018-025975.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- R01HL136575 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.